Application 017493

Type
NDA
Sponsor
BAXTER HLTHCARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRAVASOL 5.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDEINJECTABLE;INJECTION5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLNoNo
002TRAVASOL 8.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDEINJECTABLE;INJECTION8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLNoNo
003TRAVASOL 3.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDEINJECTABLE;INJECTION3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLNoNo
004TRAVASOL 5.5% W/O ELECTROLYTESAMINO ACIDSINJECTABLE;INJECTION5.5% (5.5GM/100ML)NoNo
005TRAVASOL 8.5% W/O ELECTROLYTESAMINO ACIDSINJECTABLE;INJECTION8.5% (8.5GM/100ML)NoNo
006TRAVASOL 10% W/O ELECTROLYTESAMINO ACIDSINJECTABLE;INJECTION10% (10GM/100ML)NoNo
007RENAMIN W/O ELECTROLYTESAMINO ACIDSINJECTABLE;INJECTION6.5% (6.5GM/100ML)NoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 7 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017493-001TRAVASOL 5.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 1982
N017493-002TRAVASOL 8.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 1982
N017493-003TRAVASOL 3.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 1982
N017493-004TRAVASOL 5.5% W/O ELECTROLYTESAMINO ACIDS5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N017493-005TRAVASOL 8.5% W/O ELECTROLYTESAMINO ACIDS8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N017493-006TRAVASOL 10% W/O ELECTROLYTESAMINO ACIDS10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982
N017493-007RENAMIN W/O ELECTROLYTESAMINO ACIDS6.5% (6.5GM/100ML)INJECTABLE / INJECTION1982-10-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 8 · 308 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09N017493-001TRAVASOL 5.5% W/ ELECTROLYTES5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017493-002TRAVASOL 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017493-003TRAVASOL 3.5% W/ ELECTROLYTES3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017493-004TRAVASOL 5.5% W/O ELECTROLYTES5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017493-005TRAVASOL 8.5% W/O ELECTROLYTES8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017493-006TRAVASOL 10% W/O ELECTROLYTES10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017493-007RENAMIN W/O ELECTROLYTES6.5% (6.5GM/100ML)INJECTABLE / INJECTION1982-10-15c2088c7a36db…
2026-09-14 22:38:342026-08N017493-001TRAVASOL 5.5% W/ ELECTROLYTES5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017493-002TRAVASOL 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017493-003TRAVASOL 3.5% W/ ELECTROLYTES3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017493-004TRAVASOL 5.5% W/O ELECTROLYTES5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017493-005TRAVASOL 8.5% W/O ELECTROLYTES8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017493-006TRAVASOL 10% W/O ELECTROLYTES10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017493-007RENAMIN W/O ELECTROLYTES6.5% (6.5GM/100ML)INJECTABLE / INJECTION1982-10-1584e616aacf4f…
2026-08-18 06:07:402026-07N017493-001TRAVASOL 5.5% W/ ELECTROLYTES5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017493-002TRAVASOL 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017493-003TRAVASOL 3.5% W/ ELECTROLYTES3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017493-004TRAVASOL 5.5% W/O ELECTROLYTES5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017493-005TRAVASOL 8.5% W/O ELECTROLYTES8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017493-006TRAVASOL 10% W/O ELECTROLYTES10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017493-007RENAMIN W/O ELECTROLYTES6.5% (6.5GM/100ML)INJECTABLE / INJECTION1982-10-15caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017493-001TRAVASOL 5.5% W/ ELECTROLYTES5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017493-002TRAVASOL 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017493-003TRAVASOL 3.5% W/ ELECTROLYTES3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017493-004TRAVASOL 5.5% W/O ELECTROLYTES5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017493-005TRAVASOL 8.5% W/O ELECTROLYTES8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017493-006TRAVASOL 10% W/O ELECTROLYTES10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017493-007RENAMIN W/O ELECTROLYTES6.5% (6.5GM/100ML)INJECTABLE / INJECTION1982-10-15011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-001TRAVASOL 5.5% W/ ELECTROLYTES5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-002TRAVASOL 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-003TRAVASOL 3.5% W/ ELECTROLYTES3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-004TRAVASOL 5.5% W/O ELECTROLYTES5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-005TRAVASOL 8.5% W/O ELECTROLYTES8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-006TRAVASOL 10% W/O ELECTROLYTES10% (10GM/100ML)INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017493-007RENAMIN W/O ELECTROLYTES6.5% (6.5GM/100ML)INJECTABLE / INJECTION1982-10-1531067a03dcf5…
2025-08-23 18:47 UTC2025-08N017493-001TRAVASOL 5.5% W/ ELECTROLYTES5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100MLINJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017493-002TRAVASOL 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100MLINJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017493-003TRAVASOL 3.5% W/ ELECTROLYTES3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100MLINJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017493-004TRAVASOL 5.5% W/O ELECTROLYTES5.5% (5.5GM/100ML)INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017493-005TRAVASOL 8.5% W/O ELECTROLYTES8.5% (8.5GM/100ML)INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
13155SUPPL2003-05-30
604SUPPL2003-01-17
603SUPPL2003-01-03